Clinical trial
Nebulized RNS60 for the Treatment of Amyotrophic Lateral Sclerosis
NCT02988297 is registered in ClinicalTrials.gov with Revalesio Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Nebulized RNS60 for the Treatment of Amyotrophic Lateral Sclerosis
- Lead sponsor
- Revalesio Corporation
- Phase
- Phase 2
- Overall status
- Withdrawn
- Start date
- October 31, 2026
- Completion date
- November 30, 2028
- Enrollment
- 0 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.